Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
78.22
+0.97 (1.26%)
Dec 26, 2024, 4:00 PM EST - Market closed

PRAX Revenue

Praxis Precision Medicines had revenue of $302.00K in the quarter ending September 30, 2024, a decrease of -35.47%. This brings the company's revenue in the last twelve months to $1.61M, down -16.93% year-over-year. In the year 2023, Praxis Precision Medicines had annual revenue of $2.45M.

Revenue (ttm)
$1.61M
Revenue Growth
-16.93%
P/S Ratio
n/a
Revenue / Employee
$19,573
Employees
82
Market Cap
1.46B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.45M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AtriCure 447.57M
InMode 423.75M
Phreesia 405.14M
Kiniksa Pharmaceuticals International, 384.10M
Immunocore Holdings 296.31M
Arcus Biosciences 263.00M
Travere Therapeutics 203.45M
Schrödinger 193.35M
Revenue Rankings